logo

For the Inventor, By the Inventor

Mooresville, IN, United States of America

Alexander Glenn Godfrey

USPTO Granted Patents = 14

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 83(Granted Patents)


Location History:

  • Greenwood, IN (US) (1995 - 2007)
  • Mooresville, IN (US) (2005 - 2008)

Company Filing History:

goldMedal14 out of 4,449 
 
Eli Lilly and Company
 patents
silverMedal2 out of 2 
 
Avera Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1995-2008

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7405299 - Compounds as pharmaceutical agents (2008-07-29),
2. 7351728 - Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists (2008-04-01),
3. 7345070 - Peroxisome proliferator activated receptor agonists (2008-03-18),
4. 7309702 - [object Object] (2007-12-18),
5. 7176224 - Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists (2007-02-13),
6. 7087626 - Pyrrole derivatives as pharmaceutical agents (2006-08-08),
7. 7001908 - Arylpiperazines having activity at the serotonin 1A receptor (2006-02-21),
8. 6982278 - Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists (2006-01-03),
9. 6946579 - Arylpiperazines having activity at the serotonin 1A receptor (2005-09-20),
10. 6930120 - Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists (2005-08-16),
11. 5792870 - 2-amino-3-aroyl-benzo�.beta.!thiophenes and methods for preparing and (1998-08-11),
12. 5554755 - 2-amino-3-aroyl-benzo[.beta.]thiophenes and methods for preparing and (1996-09-10),
13. 5466810 - 2-amino-3-aroyl-benzo[.beta.]thiophenes and methods for preparing and (1995-11-14),
14. 5420349 - 2-amino-3-aroyl-benzo[.beta.]thiophenes and methods for preparing and (1995-05-30),

Title: Innovations and Contributions of Alexander Glenn Godfrey

Introduction

Alexander Glenn Godfrey is a notable inventor based in Mooresville, Indiana, with a remarkable portfolio of 14 patents. His work primarily focuses on pharmaceutical compounds and their applications in treating various diseases, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest patents, Godfrey has developed compounds that serve as pharmaceutical agents. One significant invention relates to TGF-beta signal transduction inhibitors, which are crucial for treating cancer and other diseases. This invention involves compounds of a specific formula and their pharmaceutically acceptable salts. Another notable patent includes oxazolyl-aryloxyacetic acid derivatives, which are designed to modulate peroxisome proliferator-activated receptors, particularly for the treatment of diabetes mellitus. These compounds are characterized by complex structural formulas that highlight their innovative nature.

Career Highlights

Throughout his career, Godfrey has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company and Avera Pharmaceuticals, Inc. His experience in these organizations has significantly contributed to his expertise in drug development and innovation.

Collaborations

Godfrey has collaborated with several professionals in his field, including Dawn Alisa Brooks and Leonard Larry Winneroski, Jr. These collaborations have likely enriched his research and development efforts, leading to impactful inventions.

Conclusion

Alexander Glenn Godfrey's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to influence the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…